Rinet Company’s Abiomed Inc ABMD Stock Holding History

Rinet Company’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.3M	Hold	3,989	–	–	0.24%	37
2021 Q2	$1.25M	Hold	3,989	–	–	0.23%	33
2021 Q1	$1.27M	Buy	+3,989	New	+$1.28M	0.26%	33

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Rinet Company's ABMD Position: Q3 2021 in Review

Rinet Company held its Abiomed Inc (ABMD) position steady in Q3 2021 at 3,989 shares worth $1.3M. The position accounts for 0.24% of the portfolio, ranked #37.

Rinet Company first reported a position in ABMD in Q1 2021 and has held it in 3 quarters since. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

Rinet Company held 3,989 shares of Abiomed Inc worth $1.3M as of Q3 2021.
Rinet Company left its Abiomed Inc share count unchanged in Q3 2021.
Abiomed Inc made up 0.24% of Rinet Company's portfolio in Q3 2021, its #37 holding.
Rinet Company first reported a position in Abiomed Inc in Q1 2021 and has held it in 3 quarters since.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Rinet Company's 13F filing for Q3 2021, filed 12 Nov 2021.